Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein.
about
The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses.Mining human antibody repertoires.Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein.Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) CellsMining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymomaInfluenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice.Immunological assessment of influenza vaccines and immune correlates of protection.Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody.Therapeutic antibodies and infectious diseases, Tours, France, November 20-22, 2012.Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection.Influence of the Linking Order of Fragments of HA2 and M2e of the influenza A Virus to Flagellin on the Properties of Recombinant Proteins.
P2860
Q30365366-7617BE49-1719-4F57-8D75-C86FD3651D85Q30391221-43734500-A3EC-4376-BB1C-53EE2280493BQ33588489-6F11329B-5DF7-4E36-BB52-706F1DA67D60Q34099149-DCB5C032-02C1-488C-82B2-B3AF02816A5DQ34105207-B57CCEAD-41C7-491F-8748-87221BDA2F85Q35542801-43EE2026-990E-4C66-B800-86E41C68A179Q36214596-4D09B7F6-0662-47EC-A7F4-024872397F17Q36432748-702292BF-E666-4427-A96F-B5CE148BAD7AQ37069543-7F1EB718-11BB-45C2-874A-46F938B62BFAQ38105339-4237E8E1-3AA3-4BA6-AF6F-0C2687B06525Q39794523-32684400-B83A-48AA-B30B-AF00F5B2917AQ42846265-889D76FC-6480-4689-A7E3-EF28FCC5F26DQ45358078-955D787A-DBA8-4069-B7BA-3EE1BAEC5AA8Q55096280-6C3F9AFB-6538-4FD0-948B-486243516417
P2860
Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prophylactic and therapeutic a ...... gainst influenza A M2 protein.
@ast
Prophylactic and therapeutic a ...... gainst influenza A M2 protein.
@en
Prophylactic and therapeutic a ...... gainst influenza A M2 protein.
@nl
type
label
Prophylactic and therapeutic a ...... gainst influenza A M2 protein.
@ast
Prophylactic and therapeutic a ...... gainst influenza A M2 protein.
@en
Prophylactic and therapeutic a ...... gainst influenza A M2 protein.
@nl
prefLabel
Prophylactic and therapeutic a ...... gainst influenza A M2 protein.
@ast
Prophylactic and therapeutic a ...... gainst influenza A M2 protein.
@en
Prophylactic and therapeutic a ...... gainst influenza A M2 protein.
@nl
P2093
P2860
P356
P1433
P1476
Prophylactic and therapeutic a ...... gainst influenza A M2 protein.
@en
P2093
Martin F Bachmann
Monika Bauer
Myriam Gwerder
Nicole Schmitz
Philippe Saudan
Regula B Buser
Roger R Beerli
Simone Muntwiler
Wolfgang A Renner
P2860
P2888
P356
10.1186/1743-422X-6-224
P577
2009-12-21T00:00:00Z
P6179
1004405978